PrEP: latest news

PrEP resources

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • PrEP: So Effective, It's Unheard Of

    As gay, bisexual and queer men and transgender individuals get more familiar with the drug, new possibilities continue to open up for us. Even so, the general heterosexual community has shown little excitement over this breakthrough -- even a widespread ignorance to the treatment's very existence.

    27 February 2015 | The
  • UNAIDS welcomes further evidence of the efficacy of antiretroviral medicines in preventing new HIV infections

    UNAIDS strongly welcomes results from scientific trials presented at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI), held in Seattle, United States of America.

    27 February 2015 | UNAIDS
  • HIV pill: The logic of paying £500 a month so gay men don't have to wear condoms

    At a time when the NHS is under immense financial strain – some might say bankrupt – it may seem odd to suggest that the health service pay nearly £500 a month for a gay man to take a daily pill so that he doesn’t have to wear a condom. However, the scientists behind this clinical trial believe that a policy of offering daily drugs aimed at curbing new HIV infections within certain high-risk groups of men who have sex with men may actually save the NHS money in the long term.

    26 February 2015 | The Independent
  • Sexual Transmission of HCV in Gay Men Should Not Be a PrEP Deterrent, Say Advocates

    After two men on pre-exposure prophylaxis (PrEP) at the Kaiser Permanente San Francisco Medical Center tested positive for the hepatitis C virus (HCV), clinicians at the center penned a letter to the editor of the journal Clinical Infectious Diseases calling for routine HCV testing in gay men who are currently on PrEP. The two men were among 485 HIV-negative gay men receiving PrEP at the clinic between 2011 and 2014.

    26 February 2015 | The Body
  • What We Know About HIV Transmission Should Influence PrEP Messaging

    It is pretty clear that those who are diagnosed with HIV who are in care and on medicine are not spreading the virus. So why do people continue to discuss PrEP solely in the context of having known HIV-positive partners? And in what ways do we still stigmatize people living with HIV in our discussions around PrEP as a tool to bridge the viral divide?

    26 February 2015 | The Body
  • HIV treatment finally has a game-changer, and it’s called Truvada

    The widely reported Proud study shows just how effective pre-exposure prophylaxis (PrEP) can be at preventing HIV transmission. PrEP is, quite simply, a game-changer and represents a wake-up call for the government, NHS England and local authorities to make PrEP a key component in our strategy to defeat HIV.

    26 February 2015 | The Guardian
  • CDC Statement on IPERGAY Trial of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention among Men Who Have Sex with Men

    The US Centers for Disease Control (CDC) today welcomed the news of the successful findings of the PROUD and Ipergay studies but expressed caution on interpreting Ipergay's results. CDC's director of HIV/AIDS, Viral Hepatitis, STD & TB prevention said: "Since available data suggest that men in this study were taking PrEP an average of three to four days per week, CDC cautions that researchers do not yet know if this regimen will work among MSM who have sex less frequently and would therefore be taking PrEP less often." The CDC , he added, "continues to recommend only daily use of PrEP, as approved by the FDA." However he noted that "the IPERGAY findings combined with other recent research suggests that even with less than perfect daily adherence, PrEP may still offer substantial protection if taken consistently."

    25 February 2015 | CDC (US)
  • HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

    The European AIDS Treatment Group (EATG), Europe’s network of HIV activists, and  AIDES, a leading French NGO in the fight against AIDS and viral hepatitis, backed by 81 European HIV LGBT civil society organisations and concerned actors, issued an urgent HIV Prevention Manifesto today. We demand that pre-exposure prophylaxis for HIV (PrEP) is made available as soon as possible within the European Union, and that Gilead, the company that makes the PrEP medicine Truvada®, submits an application to the European Medicines Agency (EMA) for a change of indication so that its use to prevent HIV can be approved.

    25 February 2015 | EATG
  • 'Give HIV drugs to healthy gay men'

    Healthy gay men should be offered daily HIV drugs to prevent infections, say UK Medical Research Council and Public Health England scientists. Their study, on 545 high-risk men, found one case of HIV could be stopped for every 13 men treated for a year. The research team says it would be similar to the pill for women and would not encourage risky sex. The findings have been described as a "game changer" and the NHS is considering how to adopt them.

    25 February 2015 | BBC News
  • Human Rights Campaign Launches #DailyBlue Campaign Combating PrEP-Related Stigma

    Building on our endorsement of Pre-Exposure Prophylaxis (PrEP) late last year, HRC is proud to launch a new social and digital media campaign raising awareness about PrEP and encouraging people on PrEP to share their stories with friends, family and loved ones.

    24 February 2015 | Human Rights Campaign
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.